Class Attys Want OK Of $1B Deal To End Vioxx Marketing Row
By Alex Wolf ( May 25, 2016, 2:48 PM EDT) -- Class attorneys for Merck & Co. Inc. shareholders that reached a $1.06 billion deal with the pharmaceutical giant to resolve multidistrict litigation over the alleged illegal marketing of Vioxx on Tuesday urged a New Jersey federal court to approve the deal, saying that only 14 individuals and no institutional investors have objected....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.